Ardana Bioscience Ltd.
This article was originally published in Start Up
Executive Summary
A recent spin-off from the UK's government-funded Medical Research Council, Ardana Bioscience Ltd. has been set up to commercialize research into women's health. On its agenda are new products for underserved areas such as menstrual disorders and endometriosis; more convenient contraceptive drugs--including the male pill--and a product to ease childbirth. Rather than commercializing a specific patented technology, like most spin-offs, the company has the option to acquire rights to any technology generated by the MRC's Human Reproductive Sciences Unit in Edinburgh over the next five years.
You may also be interested in...
Radiopharmaceuticals: A New Frontier In Precision Cancer Therapy
Growing interest in radioligand-based cancer therapies reflects the class’s unique advantages – including the ability to “see what you treat.”
The New Antibodies Revolutionizing Medicine
Nucleic acid-based therapies are poised to revolutionize medicine – just as antibodies did thirty years ago.
What Next In Oncology?
Oncology dominates pharma sales and pipeline league tables. But where is the next Keytruda?